Arclight Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Early Stage VC
- Investors
-
5
Arclight Therapeutics General Information
Description
Operator of a biopharmaceutical incubator intended to accelerate the development of novel therapeutics for neurodegenerative diseases. The company's platform offers expertise, access to resources, and operational support to early-stage companies focused on the development of novel therapeutics for neurodegenerative diseases, enabling healthcare professionals to develop and advance their drug development programs, to bring new treatments to patients in an efficient manner.
Contact Information
Corporate Office
- 139 Main Street
- Suite 401
- Cambridge, MA 02142
- United States
Corporate Office
- 139 Main Street
- Suite 401
- Cambridge, MA 02142
- United States
Arclight Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 01-May-2024 | Completed | Startup | |||
| 2. Early Stage VC | 01-Sep-2022 | Completed | Startup | |||
| 1. Early Stage VC | 01-Jan-2020 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Arclight Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Arclight Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Arclight Therapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Dolby Family Ventures | Venture Capital | Minority | ||
| Ono Venture Investment | Corporate Venture Capital | Minority | ||
| Angelini Ventures | Corporate Venture Capital | Minority | ||
| Lumira Ventures | Venture Capital | Minority | ||
| Mission BioCapital | Venture Capital | Minority |
Arclight Therapeutics FAQs
-
When was Arclight Therapeutics founded?
Arclight Therapeutics was founded in 2020.
-
Where is Arclight Therapeutics headquartered?
Arclight Therapeutics is headquartered in Cambridge, MA.
-
What is the size of Arclight Therapeutics?
Arclight Therapeutics has 2 total employees.
-
What industry is Arclight Therapeutics in?
Arclight Therapeutics’s primary industry is Private Equity.
-
Is Arclight Therapeutics a private or public company?
Arclight Therapeutics is a Private company.
-
What is Arclight Therapeutics’s current revenue?
The current revenue for Arclight Therapeutics is .
-
Who are Arclight Therapeutics’s investors?
Dolby Family Ventures, Ono Venture Investment, Angelini Ventures, Lumira Ventures, and Mission BioCapital have invested in Arclight Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
